FORA Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,345
Closed -$654K 635
2021
Q4
$654K Buy
4,345
+170
+4% +$22.9K 0.25% 117
2021
Q3
$498K Sell
4,175
-701
-14% -$77.2K 0.13% 199
2021
Q2
$475K Buy
+4,876
New +$435K 0.09% 275
2020
Q4
Sell
-2,097
Closed -$238K 1138
2020
Q3
$238K Sell
2,097
-24,709
-92% -$2.6M 0.16% 144
2020
Q2
$2.65M Buy
26,806
+22,887
+584% +$1.83M 0.91% 11
2020
Q1
$252K Buy
+3,919
New +$275K 0.05% 396

Other funds holding TNDM

FORA Capital's TNDM Position: Q1 2022 in Review

FORA Capital sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 4,345 shares — an estimated $654K sold.

FORA Capital first reported a position in TNDM in Q1 2020 and held it in 6 quarters. The position peaked at $2.65M in Q2 2020. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • FORA Capital reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • FORA Capital sold 4,345 Tandem Diabetes Care shares in Q1 2022, an estimated $654K.
  • FORA Capital first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 6 quarters.
  • FORA Capital's Tandem Diabetes Care position peaked at $2.65M in Q2 2020.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on FORA Capital's 13F filing for Q1 2022, filed 12 May 2022.